KraigDewittMooreMD

PubMed

• Phase II study of intravenous (IV) bevacizumab and paclitaxel, and intraperitoneal (IP) cisplatin, followed by bevacizumab consolidation for advanced ovarian (O) or pe...
  McMeekin DD, Lanneau G, Curiel J, Moore K, Walker J, Mannel R> ;J. Clin. Oncol.. 2009-05-20
• 44 citations
  A Phase I Trial of Enzastaurin in Patients with Recurrent Gliomas
  Teri N. Kreisl, Lyndon Kim, Kraig Moore, Paul Duic, Svetlana Kotliarova, Jennifer Walling, Luna Musib, Donald Thornton, Paul S. Albert, Howard A. Fine> ;Clinical Cancer Research. 2009 May 15
• 1214 citations
  Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
  Teri N. Kreisl, Lyndon Kim, Kraig Moore, Paul Duic, Cheryl Royce, Irene Stroud, Nancy Garren, Megan Mackey, John A. Butman, Kevin Camphausen, John W. Park, Paul S. Alb...> ;Journal of Clinical Oncology. 2009 Feb 10
• Impact of adjuvant radiation therapy (RT) on recurrence and survival outcomes in stage IB-IIA endometrial cancer (EMCA) patients with lymph vascular invasion (LVSI).
  Simpkins F, Kunos C, Mariani A, Bakkum-Gamez J, Landrum L, Moore K, Michener C, Rose PG> ;J. Clin. Oncol.. 2008-05-20
• Human resource (HR) costs of chemotherapy infusion reactions (IR) in community oncology.
  Ogle J, Fortner BV, Moore K, Zhu L, Schwartzberg LS> ;J. Clin. Oncol.. 2006-06-20
• Human resource costs and patient time affected by the delivery of chemotherapy and neutropenia management.
  Fortner BV, Okon TA, Zhu L, Tauer K, Moore K, Templeton D> ;J. Clin. Oncol.. 2004-07-15
• 3 citations
  Changes in L1 Antigen Expression in the Rat Striatum After Substantia Nigra Lesions
  Maciej Poltorak, Jamesine R. Williams, Kraig D. Moore, Willam J. Freed> ;Journal of Neural Transplantation & Plasticity. 1997 Jan 1
• 12 citations
  In vitro properties of a newly established medulloblastoma cell line, MCD-1.
  Kraig D. Moore, Ora Dillon-Carter, Concepcion Conejero, Maciej Poltorak, Michael Chedid, Carlo Tornatore, William J. Freed> ;Molecular and Chemical Neuropathology. 1996 Oct 1
• Join now to see all